NASDAQ NMS - GLOBAL MARKET · GTBP
-4.88% · -$0.0228 · Vol 494.8K
Live · updated 12:15:25 ET
GT Biopharma Inc

GT Biopharma Inc

Biotechnology
$0.4448
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is GTBP moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About GT Biopharma Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2021
Employees
1
Country
US

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.4738
Day high
$0.4790
Day low
$0.4306
Previous close
$0.4676
52W high
$0.5140
-13.46% from high
52W low
$0.4111
33% of range
Market cap
$16.9M
EPS
$-10.3200
Shares out
36.1M
Volume
494.8K
VWAP
$0.4518
Price history computed in-house
1W
-4.98%
1M
+8.12%
SMA 50 $0.4615 · below
SMA 200 $0.4615 · below
52W position 33%
Veridion warehouse edge

Warehouse intelligence for GTBP.

Veridion Score
48
0: 871: 312: 553: 104: 795: 50
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

GTBP insider activity

GT Biopharma Inc

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for GTBP.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

GTBP contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GTBP in this window.
Lobbying spend

GTBP lobbying filings, year to date.

Registered lobbying filings matched to GT Biopharma Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GTBP in this window.
Latest news · GTBP
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for GTBP.
Options
Sovereign unlock shows live options positioning for GTBP.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.